Results 131 to 140 of about 47,373 (236)
Therapeutic Advances in Drug SafetyBackground: Aripiprazole and risperidone, widely used atypical antipsychotics, are commonly adjunctively prescribed in clinical practice. When aripiprazole was combined with risperidone, the genotype of drug-metabolizing enzymes and liver impairment may ...
Fan Mou +6 more
doaj +1 more source
Amenorrhea associated with olanzapine normalized after switching to aripiprazole: a case report
European Journal of Psychotraumatology, 2012 Background : Amenorrhea as one of frequent adverse effects associated with the use of atypical antipyschotics is often neglected but can interrupt the compliance of treatment.
Alpay Ates +5 more
doaj +1 more source
Diplopia Caused by Aripiprazole in a Depressed Patient With Healthy Eyesrt
Pharmaceutical and Biomedical Research, 2020 Background: Diplopia, or double vision, is a common ophthalmologic complaint with many underlying causes, ocular and neurological. Aripiprazole has been reported to have fewer adverse effects and better efficacy than other atypical antipsychotics ...
Hamzeh Hosseini +2 more
doaj
The normal inhibition of associations is impaired by clonidine in Tourette syndrome [PDF]
, 2011 Objective: We examined the inhibition of stimulus-stimulus associations (formally ‘conditioned inhibition’) in Tourette syndrome (TS). Method: The present study used video game style conditioned inhibition procedures suitable for children and adolescents.
Cassaday, Helen J. +3 more
core
Neuropsychiatric Disease and Treatment, 2016 Hiroko Sugawara,1,2 Kaoru Sakamoto,1 Tsuyoto Harada,3 Satoru Shimizu,4 Jun Ishigooka1 1Department of Psychiatry, Tokyo Women’s Medical University, 2Support Center for Women Health Care Professionals and Researchers, Tokyo Women’s ...
Sugawara H +4 more
doaj
Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole
Neuropsychiatric Disease and Treatment, 2017 Phyllis M Salzman,1 Arash Raoufinia,2 Susan Legacy,3 Pedro Such,4 Anna Eramo5 1Global Medical Affairs, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, 2Clinical Pharmacology, Otsuka Pharmaceutical Development & ...
Salzman PM +4 more
doaj
MetabolitesBackground/Objectives: In psychiatric disorders, antipsychotics and antidepressant medication are often administered together. Aripiprazole, a third-generation antipsychotic drug, is extensively metabolized by CYP2D6 and CYP3A4 isoenzymes, while ...
Iulia-Maria Ciocotișan +2 more
doaj +1 more source
Neuropsychiatric Disease and Treatment, 2019 Leslie Citrome,1 Yangchun Du,2 Peter J Weiden3 1Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY, USA; 2Biostatistics, Alkermes, Inc., Waltham, MA, USA; 3Medical Affairs, Alkermes, Inc., Waltham, MA, USACorrespondence: Leslie ...
Citrome L, Du Y, Weiden PJ
doaj
Solubility Behaviour of Aripiprazole in Different Solvent Systems
RGUHS Journal of Pharmaceutical SciencesBackground This current research work discusses the Aripiprazolersquos solubility behaviour in individual solvents and solvent blends to offer some theoretical foundation for the formulation scientists regarding solute solvent ...
Sharda Sambhakar +5 more
doaj +1 more source
Review of depot aripiprazole for schizophrenia
Patient Preference and Adherence, 2013 Farha Bilal Motiwala, Kim Stasia Siscoe, Rif S El-Mallakh Mood Disorders Research Program, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, KY, USA Abstract: Improving outcomes in schizophrenia ...
Motiwala FB, Siscoe KS, El-Mallakh RS
doaj